To the best of our knowledge, the role of CYP1A1 A4889G and T6235C polymorphisms in the risk, clinical features and biological characteristics of BC tumors is unknown for people living in the Southern hemisphere. This evidence concerns the gene CYP1A1 and breast cancer.